Increasing applications of human microbiome in personalized medicine and nutritional products and technological advances in metagenomics are some key factors expected to drive market revenue growth
According to Emergen Research, the global human microbiome therapeutics market size was USD 243.0 million in 2019 and is expected to reach USD 1,098.4 million in 2027 and register a revenue CAGR of 22.0%, during the forecast period, 2020-2027.
The global human microbiome therapeutics market revenue growth is majorly driven by factors such as rising prevalence of digestive diseases, metabolic disorders, infectious diseases, oncological disorders, and autoimmune disorders across the globe. Increasing instances of drug-related adverse health effects, increasing applications of human microbiome in personalized medicine, rising focus on novel drug discovery & development, and increasing collaborations between leading biotechnology companies and research organizations for research & development of advanced human microbiome therapeutics are among the other key factors supporting the growth of the global human microbiome therapeutics market revenue.
Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/280
Human microbiome plays an integral role in increasing the efficacy of various therapeutic compounds, and is thus beneficial for treatment of numerous diseases. Other key factors further driving the global market revenue growth are technological advancements in metagenomics and emergence of next-generation sequencing techniques, and increasing government investments in biotechnological research & development programs.
COVID-19 Impact Analysis:
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Probiotics Segment Accounted for Largest Revenue Share in 2019:
Based on product type, the probiotics segment accounted for the largest revenue share in the global human microbiome therapeutics market in 2019. Growing prevalence of digestive and metabolic disorders worldwide, increasing usage of probiotics (healthy gut bacteria) in the development of human microbiome therapeutics, and increasing research & development activities for advanced human microbiome therapeutics are some of the factors providing impetus to the growth of this segment.
Infectious Disease Segment to Account for Fastest Revenue CAGR:
Based on disease type, the infectious disease segment is projected to register the fastest revenue growth rate in the global human microbiome therapeutics market over the forecast period. Major factors supporting robust revenue growth of this segment are increasing instances of adverse effects of antibiotic drugs, rising incidences of infectious diseases worldwide, growing awareness of the benefits of human microbiome therapeutics in infectious disease treatment, and increasing clinical trials to develop microbiome-based therapies.
North America Accounted for Largest Revenue Share in 2019:
North America accounted for largest revenue share in the global market in 2019. Rising prevalence of chronic and acute disorders, growing geriatric population, rising demand for precision medicine, and increasing investments in microbiome research & development programs are key factors driving revenue growth of the North America market. Growing health consciousness among people, rising consumption of nutritional supplements, increased healthcare spending, and presence of major industry players in the region, including Seres Therapeutics, ViThera Pharmaceuticals, Vedanta BioSciences, Second Genome, and Synlogic, further bolster the regional market revenue growth.
Check Our Prices@ https://www.emergenresearch.com/select-license/280
Major Companies in the Global Human Microbiome Therapeutics Market Include:
- Seres Therapeutics
- ViThera Pharmaceuticals
- Vedanta BioSciences
- Second Genome
- Oxidien Pharmaceuticals, LLC
- BiomX Ltd.
- LNC Therapeutics SA
- Commense Inc.
- Embion Technologies SA
- DermBiont, Inc.
- CoreBiome, Inc.
- Carbiotix AB
- Biotagenics Inc.
- Finch Therapeutics
For the purpose of this report, Emergen Research has segmented the global human microbiome therapeutics market based on product type, approach, therapeutic area, disease type, technology, and region:
Product Type Outlook (Revenue, USD Million; 2017-2027)
- Prescription Drugs
- Medical Foods
Approach Outlook (Revenue, USD Million; 2017-2027)
- Microbial Consortia
- Phage Cocktail
- Small Molecule Therapies
- Microbial Ecosystems
- Genetically Modified Single Strain Bacteria
- Single Strain Whole Bacteria
Therapeutic Area Outlook (Revenue, USD Million; 2017-2027)
- Autoimmune Disorders
- Dermatological Disorders
- Metabolic Disorders
- Infectious Disease
Disease Type Outlook (Revenue, USD Million; 2017-2027)
- Crohn’s Disease
- Clostridium Difficile Colitis
- Irritable Bowel Syndrome
Technology Outlook (Revenue, USD Million; 2017-2027)
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/human-microbiome-therapeutics-market
Region Outlook (Revenue, USD Million; 2017-2027)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Take a Look at our Related Reports:
Flow Imaging Microscopy Market By Sample Type (Large Biomolecule, Small Biomolecules, Liquid & Viscous Samples, Microfibers and Nano fibers, Others), By Sample Dispersion (Wet Dispersion, Dry Dispersion), By End-Use (Biotechnology Companies, Pharmaceutical Companies, Water Testing Laboratories, Food & Beverage Companies, Research & Academia, Metal Manufacturing, Chemical & Petrochemical Industries), and By Region Forecast to 2028
Laboratory Centrifuges Market By Product (Equipment, Accessories), By Model (Benchtop Centrifuges, Floor-standing Centrifuges), By Usage (General Purpose Centrifuges, Preclinical Centrifuges, Clinical Centrifuges), By Rotor Design (Fixed-angle Rotors, Vertical Rotors, Swinging-bucket Rotors, Other Rotors), By Application (Diagnostics, Cellomics, Genomics, Microbiology, Blood Component Separation, Proteomics, Other), By End-Use (Hospitals, Academic & Research Institutions, Biotechnology & Pharmaceutical Companies), and By Region Forecast to 2028
RNA Transcriptomics Market By Product (Reagents, Instruments, Software, Service), By Technology (Microarrays, Polymerase Chain Reaction, RNA Sequencing, RNA Interference), By Application (Clinical Diagnostics, Toxicogenomics, Drug Discovery, Comparative Transcriptomics), By End-Use (Hospitals, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations). and By Region
Durable Medical Equipment Market By Product Type (Bathroom Safety Devices and Medical Furniture, Personal Mobility Devices, Monitoring and Therapeutic Devices), By Payer (Private, Public, Out-of-Pocket), By End-Use (Clinics, Hospitals, Long Term Care Centers, Home Care Settings, Ambulatory Surgical Centers, and Others), and By Region Forecast to 2028
Bariatric Surgery Market Size, Share, Trends, By Device (Implantable Devices, Assisting Devices), By Surgery (Invasive Surgery, Non-Invasive Surgery), By Procedure (Gastric Sleeve Surgery, Adjustable Gastric Band, Gastric Bypass), By End-use, and By Region, Forecast to 2028
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Read Full Press Release: https://www.emergenresearch.com/press-release/global-human-microbiome-therapeutics-market